Annual CFF
$2.94 M
-$72.82 M-96.13%
31 December 2023
Summary:
Compass Therapeutics annual cash flow from financing activities is currently $2.94 million, with the most recent change of -$72.82 million (-96.13%) on 31 December 2023. During the last 3 years, it has fallen by -$45.60 million (-93.95%). CMPX annual CFF is now -97.53% below its all-time high of $118.61 million, reached on 31 December 2021.CMPX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$2000.00
-$3000.00-300.00%
01 September 2024
Summary:
Compass Therapeutics quarterly cash flow from financing activities is currently -$2000.00, with the most recent change of -$3000.00 (-300.00%) on 01 September 2024. Over the past year, it has dropped by -$23.00 thousand (-109.52%). CMPX quarterly CFF is now -100.00% below its all-time high of $124.24 million, reached on 01 December 2021.CMPX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$17.27 M
-$23.00 K-0.13%
01 September 2024
Summary:
Compass Therapeutics TTM cash flow from financing activities is currently $17.27 million, with the most recent change of -$23.00 thousand (-0.13%) on 01 September 2024. Over the past year, it has dropped by -$61.57 million (-78.09%). CMPX TTM CFF is now -86.10% below its all-time high of $124.24 million, reached on 30 September 2022.CMPX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -96.1% | -109.5% | -78.1% |
| 3 y3 years | -94.0% | +99.9% | +330.3% |
| 5 y5 years | -95.4% | - | - |
CMPX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -97.5% | at low | -100.0% | +99.9% | -86.1% | +330.3% |
| 5 y | 5 years | -97.5% | -100.0% | +99.9% | -86.1% | +308.1% | |
| alltime | all time | -97.5% | -100.0% | +99.9% | -86.1% | +308.1% |
Compass Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2000.00(-300.0%) | $17.27 M(-0.1%) |
| June 2024 | - | $1000.00(-100.0%) | $17.30 M(-14.9%) |
| Mar 2024 | - | $17.43 M(<-9900.0%) | $20.33 M(+592.6%) |
| Dec 2023 | $2.94 M(-96.1%) | -$158.00 K(-852.4%) | $2.94 M(-96.3%) |
| Sept 2023 | - | $21.00 K(-99.3%) | $78.84 M(+0.0%) |
| June 2023 | - | $3.03 M(+7292.7%) | $78.83 M(+4.0%) |
| Mar 2023 | - | $41.00 K(-99.9%) | $75.80 M(+0.1%) |
| Dec 2022 | $75.76 M(-36.1%) | $75.75 M(>+9900.0%) | $75.76 M(-39.0%) |
| Sept 2022 | - | $5000.00(>+9900.0%) | $124.24 M(+1.5%) |
| June 2022 | - | $0.00(0.0%) | $122.36 M(+1.6%) |
| Mar 2022 | - | $0.00 | $120.49 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $118.61 M(+144.4%) | - | - |
| Dec 2021 | - | $124.24 M(-6725.9%) | $118.61 M(-1681.5%) |
| Sept 2021 | - | -$1.88 M(0.0%) | -$7.50 M(-9.7%) |
| June 2021 | - | -$1.88 M(0.0%) | -$8.30 M(-117.8%) |
| Mar 2021 | - | -$1.88 M(0.0%) | $46.66 M(-3.9%) |
| Dec 2020 | $48.54 M(>+9900.0%) | -$1.88 M(-30.0%) | $48.54 M(-3.7%) |
| Sept 2020 | - | -$2.68 M(-105.0%) | $50.41 M(-5.0%) |
| June 2020 | - | $53.09 M(>+9900.0%) | $53.09 M(>+9900.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $0.00(-100.0%) | - | - |
| Dec 2018 | $64.03 M | - | - |
FAQ
- What is Compass Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Compass Therapeutics?
- What is Compass Therapeutics annual CFF year-on-year change?
- What is Compass Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Compass Therapeutics?
- What is Compass Therapeutics quarterly CFF year-on-year change?
- What is Compass Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Compass Therapeutics?
- What is Compass Therapeutics TTM CFF year-on-year change?
What is Compass Therapeutics annual cash flow from financing activities?
The current annual CFF of CMPX is $2.94 M
What is the all time high annual CFF for Compass Therapeutics?
Compass Therapeutics all-time high annual cash flow from financing activities is $118.61 M
What is Compass Therapeutics annual CFF year-on-year change?
Over the past year, CMPX annual cash flow from financing activities has changed by -$72.82 M (-96.13%)
What is Compass Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CMPX is -$2000.00
What is the all time high quarterly CFF for Compass Therapeutics?
Compass Therapeutics all-time high quarterly cash flow from financing activities is $124.24 M
What is Compass Therapeutics quarterly CFF year-on-year change?
Over the past year, CMPX quarterly cash flow from financing activities has changed by -$23.00 K (-109.52%)
What is Compass Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CMPX is $17.27 M
What is the all time high TTM CFF for Compass Therapeutics?
Compass Therapeutics all-time high TTM cash flow from financing activities is $124.24 M
What is Compass Therapeutics TTM CFF year-on-year change?
Over the past year, CMPX TTM cash flow from financing activities has changed by -$61.57 M (-78.09%)